| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 30.6 | 23.2 | 9.8 |
| Other income | 0.7 | 0.1 | 0.1 |
| Total income | 31.3 | 23.3 | 9.8 |
| Profit before exceptional items & tax | 4.7 | 5.0 | 1.6 |
| Profit before tax | 4.7 | 5.0 | 1.6 |
| Net profit | 4.8 | 3.7 | 1.5 |
| Operating margin | 15.0% | 21.5% | 16.3% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +220.00% |
|---|---|
| Net profit, quarter on quarter | +29.70% |
| Revenue, year on year | +212.20% |
BSE results filing, NSE: GKSL. Figures extracted from the filing.
Gujarat Kidney and Super Speciality Ltd: key numbers
- Share price
- ₹178.02
- Market cap
- ₹1,404 Cr
- Revenue (annual)
- ₹82.01 Cr
- Net profit (annual)
- ₹15.50 Cr
- P/E (TTM)
- 88.7×Sector 57.8×
- Promoter holding
- 71.45%+0.00% QoQ
- FII holding
- 4.89%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Gujarat Kidney and Super Speciality Ltd
All →Gujarat Kidney and Super Speciality Annual Report
Gujarat Kidney and Super Speciality Limited issued a corrigendum to its FY 2025-26 Annual Report. The update includes missing Secretarial Audit observations and management responses.
Gujarat Kidney and Super Speciality Annual General Meeting
Gujarat Kidney and Super Speciality Limited has issued a notice for its 7th Annual General Meeting scheduled for September 28, 2026. The meeting will address financial statements, director appointments, and related party transactions.
- Value
- ₹1.78 Cr
Gujarat Kidney and Super Speciality Annual General Meeting
Gujarat Kidney and Super Speciality Limited filed a revised Annual Report for FY 2025-26. The document also includes the notice for its 7th Annual General Meeting.
Gujarat Kidney and Super Speciality Annual Report
Gujarat Kidney & Superspeciality Limited released its Annual Report for FY 2025-26. The report includes the notice for the 7th AGM scheduled for September 28, 2026.
Gujarat Kidney and Super Speciality Q1 FY27 Results: Net Profit ₹5.3 Cr, Down 1.9% YoY
Gujarat Kidney and Super Speciality Ltd reported revenue from operations of ₹34.3 Cr (+124.2% YoY) and net profit of ₹5.3 Cr (-1.9% YoY) for Q1 FY27.
- Key figure
- Net profit ₹5.3 Cr · -1.9% YoY